Europe Protein Expression Market Size, Share & Industry Trends Analysis Report By System (Prokaryotic, Mammalian Cell, Insect Cell, Yeast), By Product, By Application (Therapeutic, Industrial, Research), By End-user, By Country and Growth Forecast, 2022 -

Europe Protein Expression Market Size, Share & Industry Trends Analysis Report By System (Prokaryotic, Mammalian Cell, Insect Cell, Yeast), By Product, By Application (Therapeutic, Industrial, Research), By End-user, By Country and Growth Forecast, 2022 - 2028

The Europe Protein Expression Market would witness market growth of 9.8% CAGR during the forecast period (2022-2028).

Within the realm of protein expression, the foreign DNA present within the recombinant variant construct may or may not be expressed after being transplanted into the host organism. In other words, the DNA may just be copied without being expressed or it may be translated and transcribed, leading to the production of a recombinant protein. It may be possible to modify the host organism in particular ways to enhance ectopic gene expression. To improve the translation some alterations may also be required.

The creation of recombinant proteins that can enter a cell is one of the main accomplishments. By focusing on intracellular mechanisms or by using therapeutic proteins to replace intracellularly active enzymes, such advancements open up entirely new possibilities in therapeutic medicine. Escherichia coli was used as the prokaryotic system for the first expression platform to be built. Other expression systems, such as those seen in yeast, algae, insects, and mammals, developed after this.

In academic institutions like universities or research institutes, the P4EU (Protein Production and Purification Partnership in Europe) is a network whose members work on diverse areas of protein expression, purification, and characterization using core technological platforms. With the original kick-off meeting taking place in Halle, Germany in February 2011, the P4EU was envisioned in 2010. It was founded with the goal of creating a platform for the sharing of data, expertise, and resources between core facility labs working on protein expression and purification, with a strong emphasis on customer service.

The Germany market dominated the Europe Protein Expression Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $319 Million by 2028. The UK market would generate a CAGR of 8.9% during (2022 - 2028). Additionally, The France market is showcasing a CAGR of 10.7% during (2022 - 2028).

Based on System, the market is segmented into Prokaryotic, Mammalian Cell, Insect Cell, Yeast, and Others. Based on Product, the market is segmented into Reagents, Competent Cells, Instruments, Services, and Others. Based on Application, the market is segmented into Therapeutic, Industrial, Research. Based on End-user, the market is segmented into Pharmaceutical & Biotechnological Companies, Academic Research, Contract Research Organizations, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Merck Group, New England BioLabs, Inc., Promega Corporation, Qiagen N.V., Takara Bio, Inc. (Takara Holdings Inc.), Oxford Expression Technologies Ltd., and LGC Biosearch Technologies.

Scope of the Study

Market Segments covered in the Report:

By System

  • Prokaryotic
  • Mammalian Cell
  • Insect Cell
  • Yeast
  • Others
By Product
  • Reagents
  • Competent Cells
  • Instruments
  • Services
  • Others
By Application
  • Therapeutic
  • Industrial
  • Research
By End User
  • Pharmaceutical & Biotechnological Companies
  • Academic Research
  • Contract Research Organizations
  • Others
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
Companies Profiled
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific, Inc.
  • Merck Group
  • New England BioLabs, Inc.
  • Promega Corporation
  • Qiagen N.V.
  • Takara Bio, Inc. (Takara Holdings Inc.)
  • Oxford Expression Technologies Ltd.
  • LGC Biosearch Technologies
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Protein Expression Market, by System
1.4.2 Europe Protein Expression Market, by Product
1.4.3 Europe Protein Expression Market, by Application
1.4.4 Europe Protein Expression Market, by End User
1.4.5 Europe Protein Expression Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Protein Expression Market
Chapter 4. Europe Protein Expression Market by System
4.1 Europe Prokaryotic Market by Country
4.2 Europe Mammalian Cell Market by Country
4.3 Europe Insect Cell Market by Country
4.4 Europe Yeast Market by Country
4.5 Europe Others Market by Country
Chapter 5. Europe Protein Expression Market by Product
5.1 Europe Reagents Market by Country
5.2 Europe Competent Cells Market by Country
5.3 Europe Instruments Market by Country
5.4 Europe Services Market by Country
5.5 Europe Others Market by Country
Chapter 6. Europe Protein Expression Market by Application
6.1 Europe Therapeutic Market by Country
6.2 Europe Industrial Market by Country
6.3 Europe Research Market by Country
Chapter 7. Europe Protein Expression Market by End-user
7.1 Europe Pharmaceutical & Biotechnological Companies Market by Country
7.2 Europe Academic Research Market by Country
7.3 Europe Contract Research Organizations Market by Country
7.4 Europe Others Market by Country
Chapter 8. Europe Protein Expression Market by Country
8.1 Germany Protein Expression Market
8.1.1 Germany Protein Expression Market by System
8.1.2 Germany Protein Expression Market by Product
8.1.3 Germany Protein Expression Market by Application
8.1.4 Germany Protein Expression Market by End-user
8.2 UK Protein Expression Market
8.2.1 UK Protein Expression Market by System
8.2.2 UK Protein Expression Market by Product
8.2.3 UK Protein Expression Market by Application
8.2.4 UK Protein Expression Market by End-user
8.3 France Protein Expression Market
8.3.1 France Protein Expression Market by System
8.3.2 France Protein Expression Market by Product
8.3.3 France Protein Expression Market by Application
8.3.4 France Protein Expression Market by End-user
8.4 Russia Protein Expression Market
8.4.1 Russia Protein Expression Market by System
8.4.2 Russia Protein Expression Market by Product
8.4.3 Russia Protein Expression Market by Application
8.4.4 Russia Protein Expression Market by End-user
8.5 Spain Protein Expression Market
8.5.1 Spain Protein Expression Market by System
8.5.2 Spain Protein Expression Market by Product
8.5.3 Spain Protein Expression Market by Application
8.5.4 Spain Protein Expression Market by End-user
8.6 Italy Protein Expression Market
8.6.1 Italy Protein Expression Market by System
8.6.2 Italy Protein Expression Market by Product
8.6.3 Italy Protein Expression Market by Application
8.6.4 Italy Protein Expression Market by End-user
8.7 Rest of Europe Protein Expression Market
8.7.1 Rest of Europe Protein Expression Market by System
8.7.2 Rest of Europe Protein Expression Market by Product
8.7.3 Rest of Europe Protein Expression Market by Application
8.7.4 Rest of Europe Protein Expression Market by End-user
Chapter 9. Company Profiles
9.1 Thermo Fisher Scientific, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Product Launches and Product Expansions:
9.1.5.2 Acquisition and Mergers:
9.2 Agilent Technologies, Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Product Launches and Product Expansions:
9.2.5.3 Acquisition and Mergers:
9.3 Bio-Rad laboratories, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.4 Qiagen N.V.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Acquisition and Mergers:
9.5 Merck Group
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.6 Takara Bio, Inc. (Takara Holdings Inc.)
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expenses
9.7 Promega Corporation
9.7.1 Company Overview
9.8 New England BioLabs, Inc.
9.8.1 Company Overview
9.8.2 Recent strategies and developments:
9.8.2.1 Partnerships, Collaborations, and Agreements:
9.9 Oxford Expression Technologies Ltd.
9.9.1 Company Overview
9.10. LGC Biosearch Technologies
9.10.1 Company Overview

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings